Picture of Innogene Co logo

344860 Innogene Co Balance Sheet

0.000.00%
kr flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapHigh Flyer

Annual balance sheet for Innogene Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments7172,8183,19813,07213,344
Net Total Accounts Receivable
Net Total Receivables7811,0111,066995845
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets2,6485,0656,21615,47616,007
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment1,6351,5191,4451,4121,296
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets4,3906,6687,94917,20017,545
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities1,1571,1761,1751,144933
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities1,2431,2631,2051,174933
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity3,1475,4056,74416,02616,613
Total Liabilities & Shareholders' Equity4,3906,6687,94917,20017,545
Total Common Shares Outstanding